DS-Screen

Multi-center collaborative research to investigate the expression of FGFR2 and HER2 proteins in gastric, gastroesophageal junction, and colorectal cancers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080223325

Enrollment

700

Registered

2016-09-20

Start date

2016-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric, gastroesophageal junction and colorectal cancers

Interventions

investigational material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : - control material(

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Agree with ICF 20 years and older 2. Patients who are histopathologically confirmed gastric, gastroesophageal junction or colorectal cancer, and applicable for chemotherapy 3.Suppliable unstained tumor tissue slide

Exclusion criteria

Exclusion criteria: Not appropriate to this study judged by investigator or related

Design outcomes

Primary

Measure	Time frame
exploratory FGFR2 and HER2 protein expression IHC	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026